Jian-Mei Li Selected Research

Jian-Mei Li Research Topics

Disease

10	Inflammation (Inflammations) 06/2022 - 05/2004
10	Insulin Resistance 01/2017 - 05/2004
7	Cognitive Dysfunction 07/2020 - 07/2006
6	Obesity 01/2020 - 04/2005
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2015 - 12/2007
5	Hyperuricemia 02/2022 - 10/2009
5	Neoplasms (Cancer) 01/2022 - 08/2011
5	Stroke (Strokes) 08/2009 - 02/2007
5	Atherosclerosis 02/2008 - 10/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2004
4	Cardiomegaly (Heart Hypertrophy) 08/2021 - 10/2002
4	Vascular Diseases (Vascular Disease) 01/2017 - 01/2003
4	Fatty Liver 05/2010 - 05/2004
3	Neuroinflammatory Diseases 04/2022 - 11/2016
3	Nasopharyngeal Carcinoma 09/2021 - 01/2018
3	Heart Failure 08/2021 - 10/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020 - 09/2014
3	Alzheimer Disease (Alzheimer's Disease) 07/2020 - 10/2008
3	Body Weight (Weight, Body) 11/2019 - 04/2008
3	Type 2 Diabetes Mellitus (MODY) 01/2013 - 10/2004
3	Vascular System Injuries 02/2004 - 10/2002
2	Mental Disorders (Mental Disorder) 04/2022 - 04/2008
2	Hypertension (High Blood Pressure) 01/2022 - 11/2004
2	Pathologic Processes 07/2020 - 06/2015
2	Brain Injuries (Brain Injury) 07/2020 - 09/2008
2	Gliosis 01/2019 - 02/2015
2	Fibrosis (Cirrhosis) 01/2019 - 05/2004
2	Hyperinsulinism (Hyperinsulinemia) 01/2013 - 02/2008
2	Ischemia 09/2008 - 11/2004
2	Glucose Intolerance 12/2007 - 12/2006
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2007 - 07/2006
2	Hypertrophy 11/2004 - 10/2002
2	Hyperlipidemias (Hyperlipidemia) 11/2004 - 08/2003
2	Vascular Remodeling 02/2004 - 10/2002
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Fatigue 09/2021

Drug/Important Bio-Agent (IBA)

13	FructoseIBA 06/2022 - 10/2009
11	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2021 - 10/2002
10	Angiotensin IIIBA 01/2022 - 10/2003
9	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 10/2002
6	Insulin (Novolin)FDA Link 12/2015 - 05/2004
6	olmesartanIBA 12/2007 - 10/2002
4	Betaine (C.B.B.)FDA Link 01/2016 - 01/2014
4	AntioxidantsIBA 06/2015 - 11/2004
4	CytokinesIBA 02/2015 - 08/2003
4	PPAR gammaIBA 10/2008 - 05/2004
3	pterostilbeneIBA 06/2022 - 06/2015
3	Allopurinol (Remid)FDA LinkGeneric 06/2022 - 10/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2014
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2013
3	acetovanillone (apocynin)IBA 01/2020 - 11/2013
3	Small Interfering RNA (siRNA)IBA 01/2019 - 07/2006
3	InflammasomesIBA 01/2019 - 06/2015
3	CurcuminIBA 11/2016 - 05/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2016 - 02/2004
3	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 08/2003
3	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 06/2016 - 10/2002
3	Insulin ReceptorIBA 12/2015 - 11/2007
3	EnzymesIBA 09/2014 - 08/2003
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2008 - 02/2004
3	Superoxides (Superoxide)IBA 02/2008 - 02/2004
3	Messenger RNA (mRNA)IBA 09/2007 - 02/2005
3	azelnidipineIBA 12/2006 - 02/2004
2	MicroRNAs (MicroRNA)IBA 06/2022 - 12/2015
2	Volatile Fatty AcidsIBA 04/2022 - 01/2019
2	horse chestnut seedIBA 02/2022 - 09/2011
2	CoumarinsIBA 02/2022 - 09/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 10/2002
2	Oxidants (Oxidizing Agents)IBA 08/2021 - 11/2004
2	Therapeutic UsesIBA 01/2020 - 09/2011
2	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 01/2020 - 01/2009
2	NF-kappa B (NF-kB)IBA 01/2016 - 02/2005
2	LipidsIBA 01/2016 - 03/2014
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2015 - 02/2004
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 12/2015 - 05/2010
2	LeptinIBA 01/2013 - 05/2010
2	QuercetinIBA 01/2013 - 10/2009
2	Uric Acid (Urate)IBA 09/2011 - 10/2009
2	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 01/2009 - 10/2002
2	NADP (NADPH)IBA 01/2009 - 10/2002
2	Angiotensin Receptor AntagonistsIBA 12/2007 - 12/2006
2	CholesterolIBA 12/2007 - 01/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2007 - 10/2004
2	Valsartan (Vals)FDA Link 07/2006 - 05/2004
2	ApolipoproteinsIBA 07/2005 - 04/2005
2	Estrogens (Estrogen)FDA Link 04/2005 - 10/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2004 - 08/2003
2	AngiotensinsIBA 02/2004 - 10/2002
2	Polyethylene (Polythene)IBA 02/2004 - 10/2002
1	OccludinIBA 04/2022
1	Claudin-5IBA 04/2022
1	CateninsIBA 01/2022
1	Aminooxyacetic AcidIBA 01/2022
1	CystathionineIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	Plant ExtractsIBA 07/2020

Therapy/Procedure

4	Therapeutics 07/2020 - 07/2005
1	Chemoradiotherapy 09/2021